MeSH tree: D12.776.631.650.300
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO ...
Jul 12, 2025
0
35
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and liraglutide. These results ...
Jul 9, 2025
0
37
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 in the Annals of Internal ...
Jul 1, 2025
0
18
The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the condition.
Jun 26, 2025
0
23
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese patients.
Jun 23, 2025
0
19
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks.
Jun 21, 2025
0
84
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But a rise in so-called "Ozempic babies" has led the UK's medicines regulator ...
Jun 16, 2025
0
20
Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.
Jun 12, 2025
0
24
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use lower maintenance dosages. ...
Jun 10, 2025
0
38
The UK's medicine regulator warned Thursday against taking "skinny jabs" to fight weight loss if trying to get pregnant or while breastfeeding because of their unknown effects on babies.
Jun 5, 2025
0
9
